Malte is a co-founder and the CEO of CARTANA, a Stockholm-based in situ sequencing company that makes tissue in situ sequencing technology available to the global research community. From Northern Germany, Malte obtained a Master degree in Biochemistry & Cell biology at the TU Braunschweig and Lund University in Sweden. Malte then joined the Nilsson and Landegren lab at Uppsala University, where he obtained his Ph.D. in Molecular Medicine from Uppsala University & Science for Life Laboratory, Sweden. His work on single molecule analysis and sequencing technologies has resulted in several research articles and patents, which are now part of CARTANAs technology portfolio. With support from Uppsala and Stockhom-based Innovation Centers Malte successfully spun out CARTANA from the Nilsson lab, now making in situ sequencing, which has been developed in the Nilsson lab over many years, available to the research community world-wide. Besides his strong engagement for CARTANA, Malte serves as advisor to the industry advisory board for the LifeTime fetflagship project.